- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2059-0105
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Enhancing vaccine antibody responses by targeting Clec9A on dendritic cells ; volume:2 ; number:1 ; day:6 ; month:11 ; year:2017 ; pages:1-11 ; date:12.2017
npj vaccines ; 2, Heft 1 (6.11.2017), 1-11, 12.2017
- Urheber
-
Park, Hae-Young
- Beteiligte Personen und Organisationen
-
Tan, Peck S.
Kavishna, Ranmali
Ker, Anna
Lu, Jinhua
Chan, Conrad E. Z.
Hanson, Brendon J.
MacAry, Paul A.
Caminschi, Irina
Shortman, Ken
Alonso, Sylvie
Lahoud, Mireille H.
SpringerLink (Online service)
- DOI
-
10.1038/s41541-017-0033-5
- URN
-
urn:nbn:de:1111-201803141220
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
30.01.2024, 10:48 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Park, Hae-Young
- Tan, Peck S.
- Kavishna, Ranmali
- Ker, Anna
- Lu, Jinhua
- Chan, Conrad E. Z.
- Hanson, Brendon J.
- MacAry, Paul A.
- Caminschi, Irina
- Shortman, Ken
- Alonso, Sylvie
- Lahoud, Mireille H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells
A chemokine-fusion vaccine targeting immature dendritic cells elicits elevated antibody responses to malaria sporozoites in infant macaques
Transcriptional Targeting of Dendritic Cells as a New Therapeutic Vaccine against HIV-1
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Novel multifunctional antibody constructs combining antigen and adjuvant delivery to dendritic cells as a therapeutic vaccine
Targeting DNGR‐1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine
Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model
A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40
Targeting dendritic cells in pancreatic ductal adenocarcinoma
Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbp
Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells
A chemokine-fusion vaccine targeting immature dendritic cells elicits elevated antibody responses to malaria sporozoites in infant macaques
Transcriptional Targeting of Dendritic Cells as a New Therapeutic Vaccine against HIV-1
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Novel multifunctional antibody constructs combining antigen and adjuvant delivery to dendritic cells as a therapeutic vaccine
Targeting DNGR‐1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine
Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model
A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40
Targeting dendritic cells in pancreatic ductal adenocarcinoma
Crystal structure reveals vaccine elicited bactericidal human antibody targeting a conserved epitope on meningococcal fHbp
Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells
A chemokine-fusion vaccine targeting immature dendritic cells elicits elevated antibody responses to malaria sporozoites in infant macaques
Transcriptional Targeting of Dendritic Cells as a New Therapeutic Vaccine against HIV-1
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Towards antibody-mediated targeting of dendritic cells for cancer immunotherapy with multivalent polymer-antigen conjugates
Novel multifunctional antibody constructs combining antigen and adjuvant delivery to dendritic cells as a therapeutic vaccine
Targeting DNGR‐1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas
Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine
Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model
A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40
Targeting dendritic cells in pancreatic ductal adenocarcinoma